The Animal Economics logo
The Animal Economics logo
The Animal Economics amblem

Your Premier Source for AI-Powered Animal Health Business Insights

SOCIAL MEDIA LINKS

LinkedIn page
X account
Instagram profile
Facebook
YouTube channel

Virbac expands U.S. bovine portfolio with four new vaccines targeting key herd health challenges

30/10/2025

Virbac Animal Health has broadened its U.S. cattle portfolio with the launch of four new bovine vaccines aimed at protecting herds against major respiratory and reproductive diseases. The products, developed in collaboration with Diamond Animal Health, address some of the most prevalent conditions affecting animal performance and farm profitability across the U.S. beef and dairy industries.

Strengthening preventive health in the ruminant sector

Respiratory illnesses and leptospirosis remain two of the most common and costly challenges in cattle production, often reducing weight gain, reproductive performance, and overall herd productivity. By introducing targeted protection against several key pathogens — including multiple strains of bovine viral diarrhea virus (BVD) and Leptospira hardjo bovis — Virbac reinforces its position in the preventive health market, supporting veterinarians and producers with adaptable tools for different herd systems and management scales.

The company’s partnership with Diamond Animal Health leverages a century of combined experience in vaccine manufacturing and quality assurance. Dr. Fabrice Payot, vice president of new business for Virbac USA, described the collaboration as “a great pairing of companies with an excellent track record of consistent supply and proven safety.”

Market and operational focus

The launch underlines Virbac’s continued investment in the North American ruminant segment, a market characterized by growing demand for preventive and welfare-driven health solutions. The vaccines are designed to streamline veterinary practice through color-coded labels, simplifying administration in farms where multiple immunization programs are implemented.

According to Giovanni Abbruzzini, CEO and president of Virbac North America, the initiative reflects the company’s “commitment to anticipating farmer needs” and its strategic goal of reducing antibiotic use through vaccination and prevention.

As global attention intensifies on disease prevention, welfare, and antibiotic stewardship, the expansion strengthens Virbac’s commercial footprint in the U.S. while aligning with the sector’s transition toward sustainable, efficiency-driven cattle production.


The full announcement is available on Virbac’s official website.

LinkedIn page
X account
Instagram profile
Facebook link
YouTube channel

All rights reserved to The Animal Economics © Copyright 2026 | Web design & implementation: PAQ Consultancy 

This website uses cookies. For details, please see our privacy policy. By clicking on the relevant button or any other element of the page, you consent to the use of cookies.

Reject OK